This combination addresses growth hormone optimization from multiple angles
Unlike injections such as GLP-1 receptor agonists or GLP-1 and GIP drugs that provide supraphysiological dosing of GLP1 and GIP, the GLP-1 activators work internally to stimulate the bodys own production
Who Should Avoid MOTS-c Pregnant or breastfeeding individuals People with an active cancer diagnosis, since MOTS-c may affect prostate and breast cancer pathways Those taking AMPK-activating medications like metformin, thiazolidinediones, or aspirin Anyone on insulin or with uncontrolled diabetes without medical supervision Minors and adolescents Athletes in tested sports, since MOTS-c is on the WADA Prohibited List under Section S4 Anyone without access to lab-verified research peptides MOTS-c vs Other Metabolic Peptides (High-Level Comparison) MOTS-c vs Semaglutide MOTS-c works through the mitochondrial pathway with gradual, muscle-preserving results
Future studies could investigate the potential for combination therapies that leverage the mechanisms of GLP-1 alongside other diabetes medications, optimizing treatment efficacy
Most positive clinical trials used 1-2 grams daily for 8-24 weeks
Another B12 shot side effect is diarrhea, though its usually pretty mild